Exome sequencing identifies novel missense and deletion variants in RTN4IP1 associated with optic atrophy, global developmental delay, epilepsy, ataxia, and choreoathetosis. Issue 1 (9th October 2020)

• Record Type: Journal Article
• Authors: D'Gama, Alissa M.; England, Eleina; Madden, Jill A.; Shi, Jiahai; Chao, Katherine R.; Wojcik, Monica H.; Torres, Alcy R.; Tan, Wen‐Hann; Berry, Gerard T.; Prabhu, Sanjay P.; Agrawal, Pankaj B.
• Is Part Of: American journal of medical genetics. Volume 185:Issue 1(2021)
• Page Start: 203
• Page End: 207
• Publication Date: 2020-10-09
• Subjects: epilepsy -- exome sequencing -- OPA10 -- optic atrophy -- RTN4IP1; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.61910
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Inherited optic neuropathies (IONs) are neurodegenerative disorders characterized by optic atrophy with or without extraocular manifestations. Optic atrophy‐10 (OPA10) is an autosomal recessive ION recently reported to be caused by mutations in RTN4IP1, which encodes reticulon 4 interacting protein 1 (RTN4IP1), a mitochondrial ubiquinol oxydo‐reductase. Here we report novel compound heterozygous mutations in RTN4IP1 in a male proband with developmental delay, epilepsy, optic atrophy, ataxia, and choreoathetosis. Workup was notable for transiently elevated lactate and lactate‐to‐pyruvate ratio, brain magnetic resonance imaging with optic atrophy and T2 signal abnormalities, and a nondiagnostic initial genetic workup, including chromosomal microarray and mitochondrial panel testing. Exome sequencing identified a paternally inherited missense variant (c.263T>G, p.Val88Gly) predicted to be deleterious and a maternally inherited deletion encompassing RTN4IP1 . To our knowledge, this is the first report of a non‐single nucleotide pathogenic variant associated with OPA10. This case highlights the expanding phenotypic spectrum of OPA10, the association between "syndromic" cases and severe RTN4IP1 mutations, and the importance of nonbiased genetic testing, such as ES, to analyze multiple genes and variants types, in patients suspected of having genetic disease.